Press Releases

All

April 1, 2024

Rakuten Medical’s Upcoming Poster Presentation at AACR 2024: New Findings in Mouse Study to Manage Edema Associated with Photoimmunotherapy based on the Alluminox™ Platform

March 6, 2024

Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform

February 29, 2024

Over 20 Presentations on Alluminox Treatment (Photoimmunotherapy) at International Conferences in 2023

January 22, 2024

Rakuten Medical Announces First Patient Treatment in India in Global Phase 3 Trial of Alluminox Treatment (Photoimmunotherapy) using ASP-1929 for Recurrent Head and Neck Cancer

January 22, 2024

Three Invited Presentations on Alluminox Treatment (Photoimmunotherapy) at FHNO 2023

« Previous 1 2 3 4 5 6 … 16 Next »

Year Archive

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Related Content

About Us

About Us
Letter from Our CEO
Leadership
Location

About

About
Letter from Our CEO
Leadership
Location

Pipeline

Pipeline
Expanded Access Program

Pipeline

Pipeline
Expanded Access Program

News

News
Press Releases
Rakuten Medical Stories
Press Kit

News

News
Press Releases
Rakuten Medical Stories
Press Kit

Contact

Privacy Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.

Cookie Settings Accept All Cookies

Privacy & Cookies Policy

Privacy Overview

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.
Do not sell my personal information

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

SAVE & ACCEPT